# Tarsons Products Ltd (TARSONS)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹211.03
Day Change: -0.79%
52W High: ₹457.25
52W Low: ₹164.15
Market Cap: ₹1,104 Cr

## Valuation
P/E: 54.05
P/B: 1.77
EPS: ₹3.84
Book Value: ₹116.95
Dividend Yield: 0%

## Returns
1Y Return: -20.86%

## Profitability
ROE: 0%
ROCE: 6.67%
Debt/Equity: 0.63
Revenue Growth: 12.8%
Profit Growth: -4%
EBITDA Margin: 24.48%
Operating Margin: 6.01%

## About
Tarsons Products Ltd is a Medical Instruments & Supplies company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Sub Industry: Unknown

## Business Model
Overview: Tarsons Products Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Instruments & Supplies. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Announcement under Regulation 30 (LODR)-Change in Management

## Access
Current tier: anonymous
More history: Register free to see 5 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:59:06.702Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:06.702Z
Quant Updated: 2026-05-18T22:59:06.702Z
Sentiment Updated: 2026-05-18T22:59:06.702Z
Financials Status: current
Financials Updated: 2026-05-19T02:31:11.294Z
Financials Last Attempt: 2026-05-19T02:31:11.294Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹390.63 Cr
Operating Profit: ₹53.28 Cr (OPM 13.64%)
Net Profit: ₹29.77 Cr
Tax: ₹15.03 Cr

## Annual P&L History
FY25: Rev ₹390.63Cr | PAT ₹29.77Cr | OPM 13.64%
FY24: Rev ₹294.74Cr | PAT ₹42.64Cr | OPM 21.44%
FY23: Rev ₹281.36Cr | PAT ₹80.71Cr | OPM 37.14%

## Balance Sheet (FY25)
Total Assets: ₹1080.04 Cr
Total Liabilities: ₹449.83 Cr
Borrowings: ₹339.17 Cr
Cash: ₹25.13 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sanjive  Sehgal, Chairman, CEO & MD
- Santosh Kumar Agarwal, CFO, Company Secretary & Compliance Officer
- Aryan  Sehgal, Whole-time Director
- Lakshmananarayanan Balakrishna Reddy, Vice President of Operations
- Subhra Sankar Bose, Head of Human Resource

---
Source: rupiya.io/stocks/tarsons
Disclaimer: For research and education only. Not investment advice.